Elevated Fibrinogen‐Fibrin Degradation Products (FDP) in Serum of Colorectal Cancer Patients

References

• Rucklidge , G. J. , Edvardsen , K. and Bock , E. 1994 . Cell‐adhesion molecules and metalloproteinases: a linked role in tumour cell invasiveness . Biochemical Society Transaction , 22 : 63 – 68 . (Feb.)[CSA]
   Google Scholar
• Ossowski , L. , Quigley , J. P. , Kellerman , G. M. and Reich , E. 1973 . Fibrinolysis associated with oncogenic transformation . J. Exp. Med. , 138 : 1056 – 1064 . [PUBMED] [CROSSREF]
   Google Scholar
• Blackwell , K. , Haroon , Z. , Broadwater , G. , Berry , D. , Harris , L. , Iglehart , J. D. , Dewhirst , M. and Greenberg , C. 2000 . Plasma D‐dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status . J. Clin. Oncology , 18 : 600 – 608 . [CSA]
   Google Scholar
• Dirix , L. Y. , Salgado , R. , Weytjens , R. , Colpaert , C. , Benoy , I. , Huget , P. , van Dam , P. , Prove , A. , Lemmens , J. and Vermeulen , P. 2002 . Plasma fibrin D‐dimer levels correlate with tumor volume, progression rate and survival in patients with metastatic breast cancer . Bri. J. Cancer , 86 : 389 – 395 . [CROSSREF]
   Google Scholar
• Palumbo , J. S. , Kombrinck , K. W. , Drew , A. F. , Grimes , T. S. , Kise , J. H. , Degen , J. L. and Bugge , T. H. 2000 . Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells . Blood , 96 : 3302 – 3309 . [PUBMED] [CSA]
   Google Scholar
• Okholm , M. , Iversen , L. H. , Thorlacius‐Ussing , O. , Ejlersen , E. and Boesby , S. 1996 . Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma . Dis. Colon Rectum. , 39 : 1102 – 1106 . [PUBMED] [CSA]
   Google Scholar
• Gerner , C. , Steinkellner , W. , Holzman , K. , Gsur , A. , Grimm , R. , Ensinger , C. , Obrist , P. and Sauermann , G. 2001 . Elevated plasma level of crosslinked fibrinogen gamma‐chain dimmer indicate cancer‐related fibrin deposition and fibrinolysis . Thromb. Haemost. , 85 : 494 – 501 . [PUBMED] [CSA]
   Google Scholar
• Oya , M. , Akiyama , Y. , Yanagida , T. , Akao , S. and Ishikawa , H. 1998 . Plasma D‐Dimer Level in Patients with Colorectal Cancer: Its Role as a Tumor Marker . Surg. Today , 28 : 373 – 378 . [PUBMED] [CSA] [CROSSREF]
   Google Scholar
• Wu , D. , Zhou , X. , Yang , G. , Xie , Y. , Hu , M. , Wu , Z. , Yang , G. and Lu , M. 1998 . Clinical performance of the AMDL DR‐70™ immunoassay kit for cancer detection . J. Immunoassay , 19 : 63 – 72 . [PUBMED] [CSA]
   Google Scholar
• Wu , D. , Zhou , X. , Anderson , G. , Fuentes , A. , Slater , L. M. , Narinesingh , D. , Jimenez , P. and Gopoesingh , T. 1999 . Sensitivity & specificity of DR‐70™ lung cancer immunoassay . Anal. Letters , 32 ( 7 ) : 1351 – 1362 .
   Google Scholar
• Topsakal , M. , Karadeniz , T. , Anac , M. , Donmezer , S. and Besisik , A. 2001 . Assessment of fibrin‐fibrinogen degradation products (AccuDx) test in bladder cancer patients . European Urology , 39 : 287 – 291 . [PUBMED] [CSA] [CROSSREF]
   Google Scholar
• Lin , D. , Shen , P. and Yang , J. 1999 . Application of tumor marker of DR‐70® in the diagnosis of malignant tumors (translated from Chinese edition) . Chongqing Medical Journal , 28 ( 5 ) : 1 – 3 . [CSA]
   Google Scholar
• Ngo , T. T. , Cress , M. C. and Moore , R. J. 1998 . Performance characteristics of a novel immunoassay for cancer detection . IVD Technology , Jan/Feb [CSA]
   Google Scholar
• Tsihlias , J. and Grossman , H. B. 2000 . The utility of fibrin/fibrinogen degradation products in superficial bladder cancer . Urologic Clinics of North America , 27 ( 1 ) : 39 – 46 . [PUBMED] [CSA]
   Google Scholar
• McCabe , R. P. , Lamm , D. L. , Haspel , M. V. , Pomato , N. , Smith , K. O. , Thompson , E. and Hana , M. G. Jr. 1984 . A diagnostic‐prognostic test for bladder cancer using a monoclonal antibody‐based enzyme‐linked immunoassay for detection of urinary fibrin(ogen) degradation products . Cancer Research , 44 : 5886 – 5893 . [PUBMED]
   Google Scholar
• Zweig , M. H. and Robertson , E. A. 1987 . “ Clinical validation of immunoassays: A well‐design approach to a clinical study ” . In Immunoassay: A Practical Guide Edited by: Chan , D. W. and Perlstein , M. T. 97 – 127 . Orlando : Academic Press .
   Google Scholar